EUVIMEDObjevte EUVIMED
Open access

Prevalence and treatment of mental, behavioral, and developmental disorders in children with co‐occurring autism spectrum disorder and attention‐deficit/hyperactivity disorder: A population‐based study

Myriam Casseus iD, Wun Jung Kim iD, Daniel B Horton iD

Autism Research · 2023-04 · 16 (4) · 855-867

DOI: 10.1002/aur.2894 ↗

At a glance

Journal article in Autism Research, published online on 2023-01-16. Written by Myriam Casseus and 2 co-authors. Institution: Division of Population Health, Quality, and Implementation Sciences, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers University…. Major MEDLINE topics: Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder. Cited 53 times so far (Crossref); 36 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, NCATS NIH HHS, Health Resources and Services Administration.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

There is a lack of nationally representative studies examining the co‐occurrence of autism spectrum disorder (ASD) and attention‐deficit/hyperactivity disorder (ADHD) in children. This study examines comorbid mental, behavioral, and developmental disorders (MBDDs) and associated treatment modalities for children with co‐occurring ASD and ADHD. Cross‐sectional analyses were conducted using data from the pooled 2016–2018 National Survey of Children's Health (sample n = 102,341). Nationally representative prevalences were estimated for sociodemographic variables, comorbidities, psychotropic medication, and behavioral treatment. We assessed multivariable associations between co‐occurring ASD + ADHD and MBDDs, use of psychotropic medication, and receipt of behavioral treatment after adjustment for sociodemographic confounders. Compared to children with ASD without co‐occurring ADHD, children with ASD + ADHD had higher prevalence of most MBDDs, including anxiety (AOR 4.03 [95% CI 2.77, 4.87]), depression (AOR 3.08 [95% CI 1.77, 5.36]), behavior or conduct problems (AOR 4.06 [95% CI 2.72, 6.06]), and other mental health conditions. Similarly, compared to children with ADHD without ASD, children with ASD + ADHD had higher odds of anxiety (AOR 3.49 [95% CI 2.65, 4.61]), depression (AOR 1.67 [95% CI 1.21, 2.29]), behavior or conduct problems (AOR 2.31 [95% CI 1.68, 3.17]), and other mental health conditions. Children with ASD + ADHD were significantly more likely to take psychotropic medication than children with ASD without ADHD. Among children with ASD + ADHD, males had higher odds of receiving behavioral treatment, whereas older children and adolescents were more likely to take psychotropic medication. A multidisciplinary approach is necessary to support the complex needs of these children.

Subjects

MeSH terms (MEDLINE)

Attention Deficit Disorder with HyperactivityAutism Spectrum DisorderMaleAdolescentHumansChildPrevalenceDevelopmental DisabilitiesCross-Sectional StudiesPsychotropic Drugs

Author keywords

National Survey of Children's Healthattention-deficit/hyperactivity disorderautism spectrum disorderco-occurring ASD and ADHDmental and behavioral disorders

Substances

Psychotropic Drugs

Authors and institutions

  • Division of Population Health, Quality, and Implementation Sciences, Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
  • Division of Child and Adolescent Psychiatry, Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
  • Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA.
  • Rutgers School of Public Health, Piscataway, New Jersey, USA.

ORCID profiles: Myriam Casseus, Wun Jung Kim, Daniel B Horton

Funding

  • NICHD NIH HHS
  • NCATS NIH HHS
  • Health Resources and Services Administration
  • National Institutes of Health

Cite

APA

Casseus, M., Kim, W. J., & Horton, D. B. (2023). Prevalence and treatment of mental, behavioral, and developmental disorders in children with co‐occurring autism spectrum disorder and attention‐deficit/hyperactivity disorder: A population‐based study. Autism Research, 16(4), 855-867. https://doi.org/10.1002/aur.2894

Vancouver

Casseus M, Kim WJ, Horton DB. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co‐occurring autism spectrum disorder and attention‐deficit/hyperactivity disorder: A population‐based study. Autism Research. 2023;16(4):855-867. doi:10.1002/aur.2894

BibTeX
@article{Casseus2023,
  author = {Casseus, Myriam and Kim, Wun Jung and Horton, Daniel B},
  title = {Prevalence and treatment of mental, behavioral, and developmental disorders in children with co‐occurring autism spectrum disorder and attention‐deficit/hyperactivity disorder: A population‐based study},
  journal = {Autism Research},
  year = {2023},
  volume = {16},
  number = {4},
  pages = {855--867},
  doi = {10.1002/aur.2894}
}
Start for free →